A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings
Joshua P. Rosenthal(National Institutes of Health), Maggie L. Clark(Colorado State University), Lisa de las Fuentes(Washington University in St. Louis), Kalpana Balakrishnan, Ephrem Dusabimana, Eric D. McCollum(Johns Hopkins University), Kendra N. Williams(Johns Hopkins University), William Checkley(Johns Hopkins University), Steven A. Harvey(Johns Hopkins University), Anaité Díaz-Artiga(Universidad del Valle de Guatemala), Thomas Clasen(Emory University), Alejandra Bussalleu, Ghislaine Rosa(Imperial College London), Víctor G. Dávila‐Román(Washington University in St. Louis), Suzanne Simkovich(Johns Hopkins University), Miles A. Kirby(Harvard Global Health Institute), Erick Mollinedo(University of Georgia), Lisa M. Thompson(Emory University), Amy Lovvorn(Johns Hopkins University), Jennifer L. Peel(Colorado State University), Lindsay J. Underhill(Johns Hopkins University), Ashlinn Quinn(University of California, Berkeley), Bonnie N. Young(National Institutes of Health)
Cited by 11
Related Papers
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2014|1.7k
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
|Cell Metabolism|2016|866
Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019
|The Lancet Planetary Health|2020|707
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
|Journal of the American College of Cardiology|2002|518